{"id":1965,"date":"2023-05-17T12:18:26","date_gmt":"2023-05-17T06:48:26","guid":{"rendered":"https:\/\/www.cscr.res.in\/symposium\/?page_id=1965"},"modified":"2023-05-17T15:59:46","modified_gmt":"2023-05-17T10:29:46","slug":"cgt-2020","status":"publish","type":"page","link":"https:\/\/www.cscr.res.in\/symposium\/index.php\/cgt-2020\/","title":{"rendered":"CGTS-2020"},"content":{"rendered":"

PROGRAMME SCHEDULE<\/strong><\/h1>\n\n\n

CGTS 2020 SCIENTIFIC PROGRAM \u2013 Click to view \/ Download<\/strong><\/span><\/a><\/h3>\n

Time shown in IST (Indian Standard Time)<\/em><\/p>\n\n\n

DAY-1: THURSDAY, 3<\/b>rd<\/sup>\u00a0SEPTEMBER 2020<\/b><\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\u00a009:45 to 09:50 AM<\/p>\n

09:50 to 10:00 AM<\/p>\n

\u00a0<\/strong><\/p>\n

10:00 to 10:10 AM<\/p>\n<\/td>\n

\n

\u00b7 Prayer<\/p>\n

\u00b7 Welcome and introductory remarks: Dr. J. V. Peter, Director \/ Dr. Anna Pulimood, Principal, CMC \/ Dr. Alok Srivastava, Head, CSCR <\/strong><\/p>\n

\u00b7 Remarks by Dr. Renu Swarup, Secretary, Department of Biotechnology,<\/strong> Ministry of Science and Technology, Govt. of India<\/p>\n<\/td>\n<\/tr>\n

\n

Session-1: <\/em><\/strong>TECHNOLOGY ADVANCES<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/em>Vijay Chandru<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

10:15 to 10:45AM<\/p>\n<\/td>\n

\n

AAV8 gene therapy for hemophilia B<\/p>\n<\/td>\n

\n

Lakshmikanth Gandikota<\/strong><\/p>\n

Intas Pharmaceuticals, India<\/p>\n<\/td>\n<\/tr>\n

\n

10:45 to 11:15AM<\/p>\n<\/td>\n

\n

Studying DNA repair diseases using iPSCs<\/p>\n<\/td>\n

\n

R V Shaji<\/strong><\/p>\n

Centre for Stem Cell Research, and Christian Medical College Vellore, India<\/p>\n<\/td>\n<\/tr>\n

\n

11:15 to 11:45AM<\/p>\n<\/td>\n

\n

Neutral lipopolyplexes for in vivo delivery of conventional and self-amplifying RNA vaccine<\/p>\n<\/td>\n

\n

Chantal Pichon<\/strong><\/p>\n

University of Orl\u00e9ans, France<\/p>\n<\/td>\n<\/tr>\n

\n

11:45 to 12:00PM<\/p>\n<\/td>\n

\n

Break<\/em><\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

KEYNOTE ADDRESS<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/em>Alok Srivastava<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

12:00 to 01:00PM<\/p>\n<\/td>\n

\n

Gene therapy for hemoglobin disorders – What it has been and what it will be?<\/p>\n<\/td>\n

\n

Marina Cavazzana<\/strong><\/p>\n

Necker-Enfants Malades Hospital and \u00a0Institut Imagine, France<\/p>\n<\/td>\n<\/tr>\n

\n

01:00 to 2:00PM<\/p>\n<\/td>\n

\n

Poster session<\/em><\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Session-2: <\/em><\/strong>GENE EDITING<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/em>Jyotsna Dhawan<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

02:00 to 2:30PM<\/p>\n<\/td>\n

\n

Editing approaches for the treatment of \u03b2-hemoglobinopathies<\/p>\n<\/td>\n

\n

Annarita Miccio<\/strong><\/p>\n

Institut Imagine, France<\/p>\n<\/td>\n<\/tr>\n

\n

02:30 to 3:00PM<\/p>\n<\/td>\n

\n

Cas9-mediated correction of sickle mutation: Towards a clinical trial<\/p>\n<\/td>\n

\n

David Martin<\/strong><\/p>\n

Children\u2019s Hospital Oakland Research Institute, USA<\/p>\n<\/td>\n<\/tr>\n

\n

03:00 to 3:30PM<\/p>\n<\/td>\n

\n

Identification of novel HPFH-like mutations by CRISPR base editing that elevates the expression of fetal hemoglobin<\/p>\n<\/td>\n

\n

Mohankumar Murugesan<\/strong><\/p>\n

Centre for Stem Cell Research, India<\/p>\n<\/td>\n<\/tr>\n

\n

03:30 to 3:45PM<\/p>\n<\/td>\n

\n

Break<\/em><\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Session-3:<\/em><\/strong> \u00a0<\/strong>APPLICATIONS OF iPSC TECHNOLOGY<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/em>Indumathi Mariappan<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

03:45 to 4:15PM<\/p>\n<\/td>\n

\n

Quality control guidelines for the iPSCs for clinical applications<\/p>\n<\/td>\n

\n

Glyn Stacey<\/strong><\/p>\n

International Stem Cell Banking<\/p>\n

Initiative, UK<\/p>\n<\/td>\n<\/tr>\n

\n

04:15 to 4:45PM<\/p>\n<\/td>\n

\n

Eyecyte-RPE from bench to bedside- The Eyestem story<\/p>\n<\/td>\n

\n

Jogin Desai<\/strong><\/p>\n

Eyestem Research Pvt. Ltd., India<\/p>\n<\/td>\n<\/tr>\n

\n

04:45 to 5:15PM<\/p>\n<\/td>\n

\n

Autologous iPS cell based therapy for macular degeneration<\/p>\n<\/td>\n

\n

Kapil Bharti<\/strong><\/p>\n

National Institutes of Health, USA<\/p>\n<\/td>\n<\/tr>\n

\n

05:15 to 05:30PM<\/p>\n<\/td>\n

\n

Break<\/em><\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Session-4:<\/em><\/strong> GENE THERAPY<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/em>Mammen Chandy<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

05:30 to 6:00PM<\/p>\n<\/td>\n

\n

Phagocytosis-shielded lentiviral vectors for liver gene therapy of hemophilia<\/p>\n<\/td>\n

\n

Alessio Cantore<\/strong><\/p>\n

San Raffaele Telethon Institute for Gene Therapy, Italy<\/p>\n<\/td>\n<\/tr>\n

\n

06:00 to 6:30PM<\/p>\n<\/td>\n

\n

Development of NextGen AAV6 vectors for the potential gene therapy and genome editing of human hemoglobinopathies<\/p>\n<\/td>\n

\n

Arun Srivastava<\/strong><\/p>\n

University of Florida<\/p>\n

College of Medicine, USA<\/p>\n<\/td>\n<\/tr>\n

\n

06:30 to 7:00PM<\/p>\n<\/td>\n

\n

Activation of gamma globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin<\/p>\n<\/td>\n

\n

Mitchell Weiss<\/strong><\/p>\n

St. Jude Children\u2019s Research Hospital, USA<\/p>\n<\/td>\n<\/tr>\n

\n

7:00 to 7:15PM<\/p>\n<\/td>\n

\n

Break<\/em><\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Session-5: <\/em><\/strong>MANUFACTURING AND REGULATORY ASPECTS IN CELL AND GENE THERAPY<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/span><\/em>Navin Khattry<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

7:15 to 7:45PM<\/p>\n<\/td>\n

\n

Manufacturing considerations for fresh, autologous mesenchymal stromal cells for osteoarthritis<\/p>\n<\/td>\n

\n

Sowmya Viswanathan<\/strong><\/p>\n

University Health Network, Canada<\/p>\n<\/td>\n<\/tr>\n

\n

7:45 to 8:15PM<\/p>\n<\/td>\n

\n

Manufacturing of lentiviral vectors for gene therapy<\/p>\n<\/td>\n

\n

William Swaney<\/strong><\/p>\n

Expression Therapeutics, USA<\/p>\n<\/td>\n<\/tr>\n

\n

8:15 to 8:45PM<\/p>\n<\/td>\n

\n

cGMP manufacturing of cell and gene therapies<\/p>\n<\/td>\n

\n

Neehar Bhatia<\/strong><\/p>\n

Stanford University, USA<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/strong>DAY-2: FRIDAY, 4<\/b>th<\/sup>\u00a0<\/b>SEPTEMBER<\/b><\/span> 2020<\/b><\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Session-6: <\/em><\/strong>IMMUNE CELL THERAPY<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/em>Apurva Sarin<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

8:00 to 8:30AM<\/p>\n<\/td>\n

\n

Engineering gamma delta T cells for cancer immunotherapy<\/p>\n<\/td>\n

\n

Trent Spencer<\/strong><\/p>\n

Emory University<\/p>\n

School of Medicine, USA<\/p>\n<\/td>\n<\/tr>\n

\n

8:30 to 9:00AM<\/p>\n<\/td>\n

\n

Flexible, clinically adaptable, non-viral approaches to CAR-TCR methodologies<\/p>\n<\/td>\n

\n

Rama Shivakumar<\/strong><\/p>\n

MaxCyte Inc.,USA<\/p>\n<\/td>\n<\/tr>\n

\n

9:00 to 9:30AM\u00a0\u00a0\u00a0<\/p>\n<\/td>\n

\n

CAR journey in India: Discovery to Clinic<\/p>\n<\/td>\n

\n

Rahul Purwar<\/strong><\/p>\n

Indian Institute of Technology Bombay, India<\/p>\n<\/td>\n<\/tr>\n

\n

9:30 to 9:45AM<\/p>\n<\/td>\n

\n

Break<\/em><\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Session-7:<\/em><\/strong> CELL THERAPY IN MUSCULOSKELETAL DISORDERS<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/em>Prabha Nair<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

09:45 to 10:15AM<\/p>\n<\/td>\n

\n

Placenta-derived Mesenchymal Stromal Cells for in utero repair of Myelomeningocele<\/p>\n<\/td>\n

\n

Priyadarsini Kumar<\/strong><\/p>\n

University of California, Davis, USA<\/p>\n<\/td>\n<\/tr>\n

\n

10:15 to 10:45AM<\/p>\n<\/td>\n

\n

Skeletal tissue regeneration: The past and the future<\/p>\n<\/td>\n

\n

Vrisha Madhuri<\/strong><\/p>\n

Centre for Stem Cell Research and Christian Medical College Vellore, India<\/p>\n<\/td>\n<\/tr>\n

\n

10:45 to 11:15AM<\/p>\n<\/td>\n

\n

Next generation innovative stem cell-based and cell-free therapeutics for Osteogenesis imperfecta<\/p>\n<\/td>\n

\n

Pascale Guillot<\/strong><\/p>\n

University College London, UK<\/p>\n<\/td>\n<\/tr>\n

\n

11:15 to 11:30AM<\/p>\n<\/td>\n

\n

Break<\/em><\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Session-8:<\/em><\/strong> MESENCHYMAL STROMAL CELL-BASED THERAPY<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Moderator: <\/em>Sujata Mohanty<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:30 to 12:00PM<\/p>\n<\/td>\n

\n

Stem cell gene therapy for skin regeneration<\/p>\n<\/td>\n

\n

Amitava Das<\/strong><\/p>\n

CSIR-Indian Institute of Chemical Technology, India<\/p>\n<\/td>\n<\/tr>\n

\n

12:00 to 12:30PM<\/p>\n<\/td>\n

\n

Allogeneic Mesenchymal Stromal Cells Product \u2013 Stempeucel \u2013 approved in India for Critical Limb Ischemia<\/p>\n<\/td>\n

\n

Pawan Kumar Gupta<\/strong><\/p>\n

Stempeutics Research Pvt. Ltd., India<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/em><\/p>\n\n\n

CGTS 2020 ABSTRACT BOOK- <\/a>\u00a0\u2013 Click to view \/ download<\/a><\/p>\n

CGTS 2020 E-POSTER-1\u2013 Click to view \/ download<\/a>\u00a0<\/p>\n

CGTS 2020 E-POSTER-2\u2013 Click to view \/ download<\/a>\u00a0<\/p>\n

CGTS 2020 E-POSTER-3\u2013 Click to view \/ download<\/a>\u00a0<\/p>\n\n\n\n\n\n